Novo Nordisk's share price rose 13%, its biggest gain in four months.
2025-08-07 18:52:06

Novo Nordisk's stock price rose 13%, the biggest gain in four months. Eli Lilly's oral drug Orforglipron reduced body weight by an average of 11.2%, a lower-than-expected result in a trial.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download